TARSUS PHARMACEUTICALS, INC.: operating_income

Value{"amount": -143158000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Period2023-01-01 – 2023-12-31
Statuscurrent
EntityTARSUS PHARMACEUTICALS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001819790-24-000018
Retrieved: 2026-08-19T18:18:23.133294+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001819790/operating-income/2023-12-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/bef51a5c-e43b-4e34-a551-88862931f8e3

History